I-7-Fluoro-6-Nitroquinazolin-4(1H)-one CAS 162012-69-3 Ubumsulwa >99.0% (HPLC) I-Afatinib Dimaleate Intermediate Factory
I-Ruifu Chemical Supply Intermediates ye-Afatinib
I-Afatinib CAS 439081-18-2
I-Afatinib Dimaleate CAS 850140-73-7
(S)-(+)-3-Hydroxytetrahydrofuran CAS 86087-23-2
(I-Dimethylamino)i-acetaldehyde I-Diethyl Acetal CAS 3616-56-6
trans-4-Dimethylaminocrotonic Acid Hydrochloride CAS 848133-35-7
I-Diethylphosphonoacetic Acid CAS 3095-95-2
7-Fluoro-6-Nitroquinazolin-4(1H)-one CAS 162012-69-3
I-7-Chloro-6-Nitro-4-Hydroxyquinazoline CAS 53449-14-2
N-(3-Chloro-4-Fluorophenyl)-7-Fluoro-6-Nitroquinazolin-4-Amine CAS 162012-67-1
(S)-N4-(3-Chloro-4-Fluorophenyl)-7-((Tetrahydrofuran-3-yl)oxy)quinazoline-4,6-DiamineI-CAS 314771-76-1
(S)-N-(3-Chloro-4-Fluorophenyl)-6-Nitro-7-((Tetrahydrofuran-3-yl)oxy)quinazolin-4-AmineI-CAS 314771-88-5
Igama Lekhemikhali | 7-Fluoro-6-Nitroquinazolin-4(1H)-enye |
Omqondofana | I-7-Fluoro-6-Nitroquinazolin-4 (3H) -enye;I-7-Fluoro-4-Hydroxy-6-Nitroquinazoline;I-7-Fluoro-6-Nitroquinazolin-4-ol;I-7-Fluoro-6-Nitro-4-Hydroxyquinazoline;7-Fluoro-6-Nitro-1H-Quinazolin-4-one |
Inombolo ye-CAS | 162012-69-3 |
Inombolo yeCAT | I-RF-PI2025 |
Isimo Sesitoko | Esitokweni, Isikali Sokukhiqiza Sifinyelela Kumathani |
I-Molecular Formula | I-C8H4FN3O3 |
Isisindo samangqamuzana | 209.13 |
Ibhrendi | I-Ruifu Chemical |
Into | Imininingwane |
Ukubukeka | Ikristalu Ephuzi Ephuzi kuya Kubomvu noma Impushana |
1 H NMR Spectrum | Ihambisana Nesakhiwo |
Ukuhlanzeka / Indlela Yokuhlaziya | >99.0% (HPLC) |
Ukulahlekelwa Ekumisweni | <0.50% |
Ukungcola Okuphelele | <1.00% |
I-Proton NMR Spectrum | Ivumelana Nesakhiwo |
Izinga Lokuhlola | I-Enterprise Standard |
Ukusetshenziswa | I-Intermediate ye-Afatinib Dimaleate (CAS: 850140-73-7) |
Iphakheji: Ibhodlela, isikhwama se-Aluminium foil, 25kg/Cardboard Drum, noma ngokwemfuneko yekhasimende
Isimo Sesitoreji:Gcina ezitsheni ezivaliwe endaweni epholile neyomile;Vikela ekukhanyeni nakumswakama
I-7-Fluoro-6-Nitroquinazolin-4 (1H)-one (CAS: 162012-69-3) iphakathi kwe-Afatinib Dimaleate (CAS: 850140-73-7).I-Afatinib iwumndeni we-ErbB ongahlehliseki wama-blocker acindezela ukudluliswa kolwazi futhi avimbe izindlela ezinkulu ezibandakanyeka ekukhuleni kweseli lomdlavuza nokuhlukana.Ngenxa yokuthi indlela yokudlulisa ulwazi lomndeni we-ErbB ingaqalwa ama-homodimer amaningi nama-heterodimers, ukuvinjelwa ngasikhathi sinye kwamalungu amaningi omndeni we-ErbB (afana ne-EGFR, HER2, ErbB3 kanye ne-ErbB4) kungaphazamisa ngempumelelo ukudluliswa kolwazi oluya phansi.I-Afatinib isidakamizwa esigunyazwe ukwelashwa kwe-non-small cell lung carcinoma(NSCLC), esakhiwe ngu-Boehringer Ingelheim.Isebenza njenge-angiokinase inhibitor.Njenge-lapatinib ne-neratinib, i-afatinib iyi-tyrosine kinase inhibitor (TKI) ephinde ivimbele ngokungenakulungiseka i-epidermal growth factor receptor 2 (Her2) kanye ne-epidermal growth factor receptor (EGFR) kinases.I-Afatinib ayisebenzi kuphela ngokumelene nokuguqulwa kwe-EGFR okuqondiswe isizukulwane sokuqala se-TKIs likeerlotinib noma i-gefitinib, kodwa futhi ngokumelene nalezo ezingazweli kulezi zindlela zokwelapha ezijwayelekile.Ngenxa yomsebenzi wayo owengeziwe ngokumelene ne-Her2, kuphenywa umdlavuza webele kanye neminye imidlavuza eqhutshwa yi-EGFR kanye ne-Her2.